{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:41:16Z","timestamp":1773751276392,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.imlet.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T19:19:05Z","timestamp":1207941545000},"page":"82-87","source":"Crossref","is-referenced-by-count":4,"title":["Non-peptidic \u03b4-opioid receptor antagonists suppress mitogen-induced tryptophan degradation in peripheral blood mononuclear cells in vitro"],"prefix":"10.1016","volume":"118","author":[{"given":"Marcel","family":"Jenny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiana","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Spetea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Schennach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Schmidhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2008.03.006_bib1","series-title":"The pharmacological basis of therapeutics","first-page":"521","article-title":"Opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.imlet.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0008-8749(88)90208-0","article-title":"Evidence for \u03b4-class opioid receptor on cells of the immune system","volume":"116","author":"Carr","year":"1988","journal-title":"Cell Immunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.iy.06.040188.001251","article-title":"Opioid peptides and opioid receptors in cells of the immune system","volume":"6","author":"Sibinga","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.1994.2071","article-title":"Delta opioid receptor gene expression in lymphocytes","volume":"202","author":"Chuang","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.imlet.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0165-5728(01)00313-7","article-title":"Identification of delta- and mu-type opioid receptors on human and murine dendritic cells","volume":"117","author":"Makarenkova","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.imlet.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid-dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.imlet.2008.03.006_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0162-3109(92)90035-B","article-title":"Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility","volume":"23","author":"Bayer","year":"1992","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.imlet.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-2478(93)90144-Q","article-title":"Immunomodulation of human T cell responses with receptor selective enkephalins","volume":"35","author":"Mazumder","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.imlet.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000097148","article-title":"A reappraisal of the role of the various opioid receptors subtypes in cell mediated immunity","volume":"1","author":"Caroleo","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.imlet.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0196-9781(95)02051-9","article-title":"A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides","volume":"17","author":"House","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.imlet.2008.03.006_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v16.i2.10","article-title":"Opioid and opiate immunoregulatory processes","volume":"16","author":"Stefano","year":"1996","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/0-306-47611-8_31","article-title":"Lymphocyte modulation by seven transmembrane receptors: a brief review of session 1","volume":"493","author":"Sharp","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.imlet.2008.03.006_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(90)90040-T","article-title":"Corticotropin releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway","volume":"28","author":"Carr","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-3940(95)11983-4","article-title":"Suppression of immune function by non peptidic delta opioid receptor antagonists","volume":"198","author":"House","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.imlet.2008.03.006_bib17","first-page":"738","article-title":"Immunosuppression by delta opioid receptor antagonist","volume":"25","author":"Arakawa","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.imlet.2008.03.006_bib18","first-page":"696","article-title":"Immunosuppressive effects of \u03b4-opioid receptor antagonist on xenogeneic mixed lymphocyte response","volume":"24","author":"Arakawa","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1016\/j.imlet.2008.03.006_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2003.10.025","article-title":"Antibody response and allogeneic mixed lymphocyte reaction in \u03bc-, \u03b4-, and \u03ba-opioid receptor knockout mice","volume":"147","author":"Gav\u00e9riaux-Ruff","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lfs.2003.12.003","article-title":"Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activation","volume":"75","author":"D\u2019Ambrosio","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.imlet.2008.03.006_bib21","first-page":"1193","article-title":"Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu\/delta\/kappa-opioid receptor knockout mice reveal a nonopioid activity","volume":"298","author":"Gav\u00e9riaux-Ruff","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.imlet.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hlca.19980810519","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans 15. Novel \u03b4 opioid receptor antagonists with high affinity and selectivity in the 14-alkoxy-substituted indolomorphinan series","volume":"81","author":"Schmidhammer","year":"1998","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.imlet.2008.03.006_bib23","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(00)00636-1","article-title":"Inverse agonism by Dmt-Tic analogues and HS 378 a naltrindole analogue","volume":"406","author":"Labarre","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.imlet.2008.03.006_bib24","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1522-2675(20010711)84:7<2015::AID-HLCA2015>3.0.CO;2-1","article-title":"Novel delta-opioid-receptor-selective ligands in the 14-alkoxy-substituted indolo- and benzofuromorphinan series","volume":"84","author":"Biyashev","year":"2001","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.imlet.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0024-3205(01)01271-1","article-title":"Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378","volume":"69","author":"Spetea","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.imlet.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1021\/jm020940p","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinans","volume":"45","author":"Sch\u00fctz","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.imlet.2008.03.006_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.104.077321","article-title":"Inverse agonism and neutral antagonism at wild type and constitutively active mutant \u03b4 opioid receptors","volume":"313","author":"Tryoen-Toth","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.imlet.2008.03.006_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0306-4522(01)00349-9","article-title":"Selective depression of nociceptive responses of dorsal horn neurones by SNC80 in a perfused hindquarter preparation of adult mouse","volume":"107","author":"Cao","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.imlet.2008.03.006_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)00934-7","article-title":"Spinal \u03b4 opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat","volume":"418","author":"Cao","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.imlet.2008.03.006_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0704527","article-title":"Involvement of \u03bc- and \u03ba-, but not \u03b4-opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine","volume":"135","author":"Shahbazian","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.imlet.2008.03.006_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/0929867033457179","article-title":"Interferon-\u03b3-induced conversion of tryptophan: immunologic and neuropsychiatric aspects","volume":"10","author":"Wirleitner","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.imlet.2008.03.006_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production, tryptophan degradation and mental depression: what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.imlet.2008.03.006_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.imlet.2008.03.006_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon- alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.imlet.2008.03.006_bib35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1373\/clinchem.2005.064592","article-title":"In vitro testing for anti-inflammatory properties of compounds","volume":"52","author":"Winkler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.imlet.2008.03.006_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2005.03.008","article-title":"Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro","volume":"100","author":"Wirleitner","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.imlet.2008.03.006_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1084\/jem.160.1.310","article-title":"Immune response-associated production of neopterin-release from macrophages primarily under control of interferon-gamma","volume":"160","author":"Huber","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2008.03.006_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2003.02021.x","article-title":"Atorvastatin suppresses interferon-gamma-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines","volume":"131","author":"Neurauter","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2008.03.006_bib39","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/clinchem\/43.12.2424","article-title":"Simultaneous measurement of serum tryptophan and kynurenine by HPLC","volume":"43","author":"Widner","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.imlet.2008.03.006_bib40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1176\/ajp.149.9.1162","article-title":"Association of \u03b2-endorphin with specific clinical symptoms of depression","volume":"149","author":"Darko","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.imlet.2008.03.006_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(95)00067-7","article-title":"Implication of endogenous opioid system in the learned helplessness model of depression","volume":"52","author":"Tejedor-Real","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.imlet.2008.03.006_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(02)01585-6","article-title":"Differential effects of chronic antidepressant treatments on \u03bc- and \u03b4-opioid receptors in rat brain","volume":"443","author":"Vipoux","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.imlet.2008.03.006_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schroecksnadel","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.imlet.2008.03.006_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: Evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247808000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247808000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T04:42:17Z","timestamp":1588567337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247808000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0165247808000916"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2008.03.006","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}